Seerave Foundation

Vision

Seerave's vision is that every cancer patient has access to personalised, integrative treatment and care.

Our Purpose

Seerave aims to improve cancer patients' lives by leveraging the symbiosis between their immune system and the microbiome.

What We Do

A platform for science and venture philanthropy

Seerave is on a mission to improve cancer patients' lives by leveraging the symbiosis between their immune system and the microbiome.

We do this by supporting collaborative, cross-disciplinary academic endeavors and early-stage ventures turning scientific insights into novel clinical tools.

Our project portfolio is built around international alliances of world-leading institutions, visionary scientists and entrepreneurs.

Our Projects

About Us

Proactive Family Foundation

Inspired by personal experiences, Seerave was founded in 2015, driven by the conviction that the nutrition-microbiome-immune system axis is a significant contributor to the future of personalised cancer treatment.

About Seerave

Immune System
Symbiosis
Microbiome
Personalised Cancer Treatments
Immune System
Symbiosis
Microbiome
Personalised Cancer Treatments
Immune System
Symbiosis
Microbiome
Personalised Cancer Treatments
Immune System
Symbiosis
Microbiome
Personalised Cancer Treatments

Involved
Pragmatic
Proactive
Collaborative
Open Science
Integrative
Involved
Pragmatic
Proactive
Collaborative
Open Science
Integrative
Involved
Pragmatic
Proactive
Collaborative
Open Science
Integrative
Involved
Pragmatic
Proactive
Collaborative
Open Science
Integrative

Data Integration
Translational Science
Clinical Guidelines
Advocacy
Novel Tools
Data Integration
Translational Science
Clinical Guidelines
Advocacy
Novel Tools
Data Integration
Translational Science
Clinical Guidelines
Advocacy
Novel Tools
Data Integration
Translational Science
Clinical Guidelines
Advocacy
Novel Tools

Learn about our approach

Latest

Explore our selection of research articles and news

Seerave Publication

Seerave invests in Florey Biosciences and takes aim at mitigating impacts of antibiotic use

Oct / 2024

Seerave Publication

Seerave Announces Strategic Focus on Antibiotics and Cancer Immunotherapy

Jul / 2024

Seerave Translational

Funder Impact Roundtable

Feb / 2024

FAQ

I would like to ask you about...

Seerave is a proactive family Foundation established in Jersey (Channel Islands). We are inspired by personal experiences and driven by the conviction that through collaboration we will be able to accelerate science and catalyse innovation to enable our vision that every cancer patient has access to personalised, integrative treatment and care.

Seerave uses a combination of traditional grant donations for academic researchers as well as equity investments into early-stage start-ups. All of our collaborations are mission-aligned. Our project portfolio is built around international alliances of world-leading institutions, visionary scientists and entrepreneurs.

Yes. Seerave Foundation is a registered NPO under Non-Profit Organisations (Jersey) Law 2008, with registration number NPO-7095.

The funding comes from a family endowment. David Rees co-founded the downstream oil company Greenergy, which was sold in May 2017 and the resulting proceeds were bequeathed to Seerave to fund its philanthropic activities.

Hint: read it backwards. Seerave is named for Eva Rees, whose experience fighting metastatic melanoma inspired her husband David to establish the Foundation in 2015. It is pronounced SEE-rayv.

Read all FAQ